panitumumab (Vectibix)
panitumumab is an FDA-licensed reference biologic from Amgen Inc.. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2006
Reference approved
Reference product
Vectibix panitumumab
Amgen Inc.
- Approved
- Sep 27, 2006
- Marketing
- Rx
- Center
- CDER
- Patents
- None listed
Molecular structure
Experimental 3D structure for panitumumab from the RCSB Protein Data Bank (PDB 5SX4).
Interactive biological assembly from PDB entry 5SX4. Drag to rotate, scroll to zoom, and inspect the full atomic structure right here — no need to leave the page.
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for panitumumab, in chronological order.
Reference approval
Approval date of the reference panitumumab product.
20 yr ago
Frequently asked questions
Are there biosimilars approved for panitumumab (Vectibix)?
No 351(k) biosimilars or interchangeable biosimilars referencing panitumumab are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.